Atara Biotherapeutics, Inc.ATRANASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank69
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-50.94M
↑ 67% vs avg
Percentile
P69
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
$-154.73M
Historical baseline
PeriodValueYoY Change
TTM$-50.94M+25.9%
2024$-68.72M+64.4%
2023$-192.98M+28.6%
2022$-270.43M-22.6%
2021$-220.52M-22.0%
2020$-180.76M+23.3%
2019$-235.63M-31.1%
2018$-179.77M-105.4%
2017$-87.50M-45.8%
2016$-60.02M-